XKH-001(Xinkanghe Biomedical)

N/A

Report date: 2026/04/10 20:01:49

Base Information

Drug NameXKH-001(Xinkanghe Biomedical)
Drug Alias NameXKH-001注射液XKH-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-25 inhibitors
TargetsInterleukin-25
Therapy Area/IndicationsAllergic asthmaInflammationDermatitis, Atopic +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsAllergic asthmaInflammationDermatitis, Atopic +[6
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A